1. Indonesia Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
PT Soho Global Health Tbk

PT Soho Global Health Tbk

IIDX:SOHO
1,255.00
IDR
-30.00
(-2.33%)
53.81EPS
19.70P/E
13.45TMarket Cap
PT Soho Global Health Tbk
IDX:SOHO
(Indonesia Stock Exchange)

Recent

price

1,255.00

P/E

ratio

19.70

div

yld

5.26%

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
IDR
397.76
684.65
557.54
574.4
645.92
792.48
849.31
864.55
Revenue per Share
9.33
19.12
43.35
28.11
29.26
36.45
47.3
53.81
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
0.58
1.5
43.3
11.8
31.5
12
23.7
66.06
Dividend per Share
103.41
173.69
173.95
191.27
189.03
213.94
203.52
193.4
Book Value per Share
100.94
171.46
171.91
189.18
187.44
212.67
202.41
192.39
Tangible Book Value per Share
12,692
9,003
12,692
12,692
12,692
12,692
12,692
12,692
Basic Weighted Avg Shares
5,048,301
6,163,939
7,076,164
7,290,121
8,197,755
10,057,938
10,779,187
10,972,612
Sales/Revenue/Turnover
4.36
3.81
9.14
6.04
5.24
5.61
6.76
7.78
Operating Margin (%)
24,996
46,620
47,101
46,364
50,764
48,940
48,440
50,159
Depreciation Expense
118,457
172,108
550,176
356,728
371,341
462,651
600,321
682,883
Net Income, GAAP
38.35
31.03
20.27
21.64
19.87
21.32
22.22
22.31
Effective Tax Rate (%)
2.35
2.79
7.78
4.89
4.53
4.6
5.57
6.22
Profit Margin (%)
543,980
1,608,549
1,687,122
1,974,504
1,953,907
2,222,785
2,138,354
2,029,819
Working Capital
- -
24,258
18,540
12,916
9,440
6,688
3,499
2,631
LT Debt
1,313,993
2,206,102
2,208,291
2,427,555
2,399,098
2,715,216
2,583,002
2,454,603
Total Equity
- -
8.7
23.65
14.7
14.45
17.43
21
24.72
Return on Invested Capital (%)
- -
9.01
24.66
15.28
15.31
18.02
22.58
26.39
Return on Capital (%)
- -
9.79
24.94
15.39
15.39
18.09
22.66
26.47
Return on Common Equity (%)

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
3,720
1,833
1,873
LT Borrowings
- -
- -
- -
LT Finance Leases
3,499
3,266
2,631
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12,692
12,692
12,692
Market Capitalization
17,387,605
25,383,365
13,453,183

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,514,743
5,152,820
4,966,088
Cash, Cash Equivalents & STI
1,104,126
818,826
720,577
Accounts Receivable, Net
1,987,071
2,146,728
2,147,109
Inventories
1,562,326
1,503,919
1,493,876
Total Current Liabilities
3,376,389
2,818,945
2,936,269
Payables & Accruals
- -
- -
- -
ST Debt
3,720
1,833
1,873
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
3.43%
-4.87%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
48.59%
29.76%
Sales/Revenue/Turnover
- -
12.03%
7.17%
Total Cash Common Dividend
- -
821.38%
97.5%

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,443,817
2,437,302
2,589,575
2,587,244
10,057,938
2025
2,670,918
2,498,075
2,755,513
2,854,681
10,779,187
2026
2,635,637
2,726,781
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9.96
7.82
9.13
9.55
36.45
2025
10.5
12.38
11.8
12.62
47.3
2026
14.96
14.42
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
12
2025
- -
- -
- -
- -
23.7
2026
33.1
32.96
- -
- -
- -
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
PT Soho Global Health Tbk (SOHO.JK) operates as an integrated healthcare company in Indonesia, focusing on the research, development, manufacturing, and distribution of herbal-based medicines and related health products. The company offers a portfolio of nonprescription consumer health brands including Imboost and Imboost Force for immune support, Curcuma Plus Milk and Multivitamins for child nutrition and growth, Diapet for digestive health, Fitkom children's multivitamins, Curcuma Group for liver function and appetite enhancement, Lelap, Asthma Soho, Sohobion, and Asthin antioxidants; it also provides contract manufacturing services across various dosage forms, distribution and logistics through subsidiary PT Parit Padang Global, medical devices in wound care, orthopedics, surgery, and in-vitro diagnostics, alliance and in-licensing partnerships for multinational products, product registration, marketing intelligence, and sales support services. PT Soho Global Health Tbk serves segments encompassing Distribution, Professional Products, Consumer Health, Alliance, and Others, targeting healthcare professionals, pharmacies, hospitals, and general consumers primarily in Indonesia with selective ASEAN presence. Founded in 1946 and headquartered in Jakarta, Indonesia, the company maintains operations centered in the domestic market while leveraging global research collaborations such as with Soho Flordis International for natural ingredient development. Recent developments include multiple distribution partnership expansions by subsidiary PT Parit Padang Global, such as agreements signed in January 2025 with PT Mitra Mas Sentosa for Cool-Vita vitamin supplements, in April 2025 with PT Ichiya Indonesia for Okamoto branded products, and additional collaborations with PT Sea Makeup Beauty for The Originote and others in 2025; further, a June 2025 memorandum of understanding with RSUP Dr. Sardjito establishes strategic ties in education, research, and pharmaceuticals.